GLP-1 Receptor Agonists and Uses Thereof
US-2025340544-A1 · Nov 6, 2025 · US
This page is not indexed by search engines while we improve data quality.
Flanagan Mark E patents
Flanagan Mark E is listed as an inventor on 30 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Flanagan Mark E |
| Total patents | 30 |
| First publication | Jun 21, 2018 |
| Latest publication | Nov 6, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
GLP-1 Receptor Agonists and Uses Thereof
US-2025270196-A1 · Aug 28, 2025 · US
Glp-1 receptor agonists and uses thereof
US-2025257052-A1 · Aug 14, 2025 · US
GLP-1 receptor agonists and uses thereof
US-12378230-B2 · Aug 5, 2025 · US
GLP-1 receptor agonists and uses thereof
US-12331041-B2 · Jun 17, 2025 · US
GLP-1 receptor agonists and uses thereof
US-12319669-B2 · Jun 3, 2025 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2024132483-A1 · Apr 25, 2024 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2024059679-A1 · Feb 22, 2024 · US
Glp-1 receptor agonists and uses thereof
US-2024034725-A1 · Feb 1, 2024 · US
GLP-1 receptor agonists and uses thereof
US-11858916-B2 · Jan 2, 2024 · US
Recent patents
Latest publications not already listed above.
GLP-1 receptor agonists and uses thereof
US-11802121-B2 · Oct 31, 2023 · US
Glp-1 receptor agonists and uses thereof
US-2023124938-A1 · Apr 20, 2023 · US
Solid Forms of 2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine Salt
US-2023045419-A1 · Feb 9, 2023 · US
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
US-2022387402-A1 · Dec 8, 2022 · US
GLP-1 receptor agonists and uses thereof
US-11512070-B2 · Nov 29, 2022 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2021332034-A1 · Oct 28, 2021 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2021163455-A1 · Jun 3, 2021 · US
GLP-1 receptor agonists and uses thereof
US-10934279-B2 · Mar 2, 2021 · US
Glp-1 receptor agonists and uses thereof
US-2021047298-A1 · Feb 18, 2021 · US
GLP-1 receptor agonists and uses thereof
US-10851081-B2 · Dec 1, 2020 · US
Glp-1 receptor agonists and uses thereof
US-2020255406-A1 · Aug 13, 2020 · US
GLP-1 receptor agonists and uses thereof
US-10683281-B2 · Jun 16, 2020 · US
GLP-1 receptor agonists and uses thereof
US-10676465-B2 · Jun 9, 2020 · US
GLP-1 receptor agonists and uses thereof
US-10669259-B2 · Jun 2, 2020 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2019382387-A1 · Dec 19, 2019 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2019382388-A1 · Dec 19, 2019 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2019382384-A1 · Dec 19, 2019 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2019119255-A1 · Apr 25, 2019 · US
GLP-1 receptor agonists and uses thereof
US-10208019-B2 · Feb 19, 2019 · US
GLP-1 Agonists and Uses Thereof
US-2018170908-A1 · Jun 21, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Pfizer | 30 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/04 | 30 |
| C07D405/14 | 29 |
| A61P3/00 | 29 |
| A61P3/10 | 29 |
| C07D413/14 | 28 |